Prostate Cancer Foundation Clinical Research Consortium
The investigators will collect a blood sample for the study when the participant has other blood tests drawn for their cancer treatment. The investigators will take one sample to check prostate specific antigen (PSA) levels and another blood sample for CTC analysis. The investigators will be drawing blood at the following time points: Screening; One day after surgery; 7-14 days after surgery; 3-6 months after surgery; at PSA recurrence or at two years.
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male
18 years of age or older
Pathologically confirmed diagnosis of prostate adenocarcinoma
Non-metastatic prostate cancer
Planned radical prostatectomy at Massachusetts General Hospital
You may not be if
Patients must not have received prior radiation therapy, hormone therapy, or other medical therapy for prostate cancer prior to prostatectomy. Post-prostatectomy therapy at the discretion of the patient's treating physician(s) is allowed.
Patients must not have metastatic prostate cancer
No prior or current diagnosis of epithelial malignancy, except for skin cancer (squamous cell carcinoma or basal cell carcinoma)
